GlassScriptPhysician profile
Larry C Sexton
NPI 1396849980
$15,010.47
in general payments reported to CMS, 2019-2025
16 companies · $3,032 in 2025
The $3,032 reported for 2025 was more than what 96% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,491 · 2022: $2,698 · 2023: $3,468 · 2024: $3,321 · 2025: $3,032.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,647 · Education: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,647.07 |
| Education | $174.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $2,115.56 | 2021-2025 | Spravato, Invega Sustenna, Invega Trinza |
| Alkermes, INC. | $1,948.52 | 2021-2025 | Aristada, Lybalvi, Vivitrol |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,597.99 | 2021-2025 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $1,487.30 | 2022-2025 | Uzedy, Austedo, Austedo Xr |
| Abbvie INC. | $1,457.69 | 2021-2024 | |
| Otsuka America Pharmaceutical, INC. | $1,400.46 | 2021-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Neurocrine Biosciences, INC. | $985.42 | 2021-2025 | Ingrezza |
| Lundbeck LLC | $923.35 | 2022-2025 | Rexulti |
| Sunovion Pharmaceuticals INC. | $901.64 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $710.30 | 2021-2025 | Trintellix |
| Axsome Therapeutics, INC. | $543.01 | 2022-2025 | Auvelity |
| Vanda Pharmaceuticals INC. | $412.07 | 2024-2025 | Fanapt |
| E.R. Squibb & Sons, L.L.C. | $323.28 | 2024-2025 | Cobenfy |
| Braeburn INC. | $100.28 | 2024-2025 | Brixadi |
| Corium, LLC | $72.94 | 2022-2023 | Azstarys |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $30.66 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Sexton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.